Literature DB >> 12729584

Mammalian mitochondrial IAP binding proteins.

David L Vaux1, John Silke.   

Abstract

Four mitochondrial proteins have been identified that immunoprecipitate with the mammalian inhibitor of apoptosis (IAP) protein XIAP. Each of them interacts via a processed amino terminus that resembles those of the insect pro-apoptotic IAP binding proteins Grim, HID, Reaper, and Sickle. Two, Diablo/Smac and HrtA2/Omi, have been extensively characterized. Both Diablo and HtrA2 can bind to IAPs and promote apoptosis when over-expressed in transfected cells, but unlike the insect IAP antagonists, to date there is scant evidence that they are important regulators of apoptosis in more physiological circumstances.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12729584     DOI: 10.1016/s0006-291x(03)00622-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  69 in total

1.  The mitochondrial ARTS protein promotes apoptosis through targeting XIAP.

Authors:  Yossi Gottfried; Asaf Rotem; Rona Lotan; Hermann Steller; Sarit Larisch
Journal:  EMBO J       Date:  2004-03-18       Impact factor: 11.598

Review 2.  Death receptor signals to mitochondria.

Authors:  Roya Khosravi-Far; Mauro Degli Esposti
Journal:  Cancer Biol Ther       Date:  2004-11-18       Impact factor: 4.742

3.  Combined treatment with TRAIL and PPARγ ligands overcomes chemoresistance of ovarian cancer cell lines.

Authors:  Karen Bräutigam; Julia Biernath-Wüpping; Dirk O Bauerschlag; Constantin S von Kaisenberg; Walter Jonat; Nicolai Maass; Norbert Arnold; Ivo Meinhold-Heerlein
Journal:  J Cancer Res Clin Oncol       Date:  2010-09-29       Impact factor: 4.553

4.  Variations in the protein level of Omi/HtrA2 in the heart of aged rats may contribute to the increased susceptibility of cardiomyocytes to ischemia/reperfusion injury and cell death : Omi/HtrA2 and aged heart injury.

Authors:  Ke Wang; Jie Zhang; Jingyi Liu; Jue Tian; Ye Wu; Xiaoliang Wang; Lin Quan; Haibo Xu; Wen Wang; Huirong Liu
Journal:  Age (Dordr)       Date:  2012-04-26

Review 5.  Reawakening the cellular death program in neoplasia through the therapeutic blockade of IAP function.

Authors:  Casey W Wright; Colin S Duckett
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

Review 6.  Inhibitor of apoptosis proteins in eukaryotic evolution and development: a model of thematic conservation.

Authors:  Mary X D O'Riordan; Laura D Bauler; Fiona L Scott; Colin S Duckett
Journal:  Dev Cell       Date:  2008-10       Impact factor: 12.270

7.  IAP-antagonists exhibit non-redundant modes of action through differential DIAP1 binding.

Authors:  Anna Zachariou; Tencho Tenev; Lakshmi Goyal; Julie Agapite; Hermann Steller; Pascal Meier
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

8.  Elevated XIAP expression alone does not confer chemoresistance.

Authors:  J M Seeger; K Brinkmann; B Yazdanpanah; D Haubert; C Pongratz; O Coutelle; M Krönke; H Kashkar
Journal:  Br J Cancer       Date:  2010-05-18       Impact factor: 7.640

9.  Drosophila HtrA2 is dispensable for apoptosis but acts downstream of PINK1 independently from Parkin.

Authors:  L S Tain; R B Chowdhury; R N Tao; H Plun-Favreau; N Moisoi; L M Martins; J Downward; A J Whitworth; N Tapon
Journal:  Cell Death Differ       Date:  2009-03-13       Impact factor: 15.828

10.  Two distinct signalling cascades target the NF-kappaB regulatory factor c-IAP1 for degradation.

Authors:  Rebecca A Csomos; Casey W Wright; Stefanie Galbán; Karolyn A Oetjen; Colin S Duckett
Journal:  Biochem J       Date:  2009-04-28       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.